MTATP8P2

Across TCGA pan-cancer cohorts, MTATP8P2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MTATP8P2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MTATP8P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTATP8P2 expression acts as an unfavorable survival marker, although some lineages such as ACC and THCA show a favorable association.

ACC, DLBC, and SKCM are the cancer types where MTATP8P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.639	0.279	<.001	75	view →
DLBC	DFS	Tertile	II,III,IV	0.134	0.984	.005	38	view →
SKCM	DFS	Median	All	0.671	0.778	.007	36	view →
THCA	DFS	Median	II,III,IV	0.918	0.260	<.001	35	view →
KICH	OS	Median	All	1.000	0.700	.005	30	view →
HNSC	DFS	Median	IV	0.619	0.296	<.001	29	view →
LIHC	DFS	Quartile	All	0.688	0.322	<.001	29	view →
READ	OS	Quartile	II,III,IV	0.814	0.263	.001	28	view →
BLCA	OS	Median	All	0.722	0.443	.001	27	view →
COAD	DFS	Median	All	0.412	0.639	.001	20	view →
UCEC	DFS	Tertile	All	0.573	0.789	.019	20	view →
UCS	DFS	Median	III,IV	0.396	0.160	.035	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

MTATP8P2–ACC (DFS)

Open the ACC breakdown →